Erythromycin and simvastatin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Erythromycin can increase statin myopathy risk
Macrolides such as erythromycin can inhibit simvastatin metabolism and increase myopathy or rhabdomyolysis risk. The prescriber may need to choose an alternative antibiotic or pause the statin. Previous statin muscle symptoms increase the importance of counselling and review.
Reference: BNF